Published on August 25, 2010 at 8:10 AM
"tranSMART has garnered numerous accolades from across the industry for its ability support the future of translational medicine. Recombinant and Johnson & Johnson are hopeful that the capabilities of tranSMART will be available to a broader consortium of commercial and academic organizations involved in drug development," said Peter Emerson, CEO, Recombinant Data Corp. "Congratulations to the entire team at Johnson & Johnson for their commitment to the success of tranSMART."
Each year, the CIO 100 Awards honor companies that demonstrate excellence and achievement through an innovative use of technology that delivers competitive advantage to the enterprise. The award ceremony will occur at the CIO Symposium on August 24, 2010 in Ranchos Palos Verdes, California.
SOURCE Recombinant Data Corp.